Zobrazeno 1 - 10
of 740
pro vyhledávání: '"Medical Countermeasures"'
Autor:
Swenson J; Biomedical Advanced Research and Development Authority, Administration for Strategic Preparedness and Response, US Department of Human and Health Services, Washington, District of Columbia, USA., Disbrow G; Biomedical Advanced Research and Development Authority, Administration for Strategic Preparedness and Response, US Department of Human and Health Services, Washington, District of Columbia, USA., Johnson RA; Biomedical Advanced Research and Development Authority, Administration for Strategic Preparedness and Response, US Department of Human and Health Services, Washington, District of Columbia, USA.
Publikováno v:
The Journal of infectious diseases [J Infect Dis] 2024 Jul 25; Vol. 230 (1), pp. e1-e3.
Gastrointestinal Acute Radiation Syndrome: Mechanisms, Models, Markers, and Medical Countermeasures.
Autor:
Winters TA; Radiation and Nuclear Countermeasures Program (RNCP), Division of Allergy, Immunology and Transplantation (DAIT), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Rockville, Maryland., Marzella L; Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration (FDA), Silver Spring, Maryland., Molinar-Inglis O; Radiation and Nuclear Countermeasures Program (RNCP), Division of Allergy, Immunology and Transplantation (DAIT), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Rockville, Maryland., Price PW; Office of Regulatory Affairs, DAIT, NIAID, NIH, Rockville, Maryland., Han NC; Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration (FDA), Silver Spring, Maryland., Cohen JE; Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration (FDA), Silver Spring, Maryland., Wang SJ; Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration (FDA), Silver Spring, Maryland., Fotenos AF; Center for Drug Evaluation and Research (CDER), U.S. Food and Drug Administration (FDA), Silver Spring, Maryland., Sullivan JM; Center for Devices for Radiological Health (CDRH), FDA, Silver Spring, Maryland., Esker JI; Biomedical Advanced Research and Development Authority (BARDA), Office of the Assistant Secretary for Preparedness and Response (ASPR), Department of Health and Human Services (HHS), Washington, DC., Lapinskas PJ; Biomedical Advanced Research and Development Authority (BARDA), Office of the Assistant Secretary for Preparedness and Response (ASPR), Department of Health and Human Services (HHS), Washington, DC., DiCarlo AL; Radiation and Nuclear Countermeasures Program (RNCP), Division of Allergy, Immunology and Transplantation (DAIT), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Rockville, Maryland.
Publikováno v:
Radiation research [Radiat Res] 2024 Jun 01; Vol. 201 (6), pp. 628-646.
Autor:
Cassatt DR; Radiation and Nuclear Countermeasures Program (RNCP), Division of Allergy, Immunology and Transplantation (DAIT), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Rockville, Maryland., DiCarlo AL; Radiation and Nuclear Countermeasures Program (RNCP), Division of Allergy, Immunology and Transplantation (DAIT), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Rockville, Maryland., Molinar-Inglis O; Radiation and Nuclear Countermeasures Program (RNCP), Division of Allergy, Immunology and Transplantation (DAIT), National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Rockville, Maryland.
Publikováno v:
Radiation research [Radiat Res] 2024 May 01; Vol. 201 (5), pp. 471-478.
Autor:
Maciulewicz TS; Arizona Poison and Drug Information Center, College of Pharmacy, University of Arizona, Tucson, Arizona, USA.; Department of Pharmacy Practice and Science, College of Pharmacy, University of Arizona, Tucson, Arizona, USA.; Chemical, Biological, Radiological, & Nuclear (CBRN) Focus Group, Pediatric Countermeasures Sub-Group, Western Regional Alliance for Pediatric Emergency Management (WRAP-EM), Oakland, California, USA., Kazzi Z; Chemical, Biological, Radiological, & Nuclear (CBRN) Focus Group, Pediatric Countermeasures Sub-Group, Western Regional Alliance for Pediatric Emergency Management (WRAP-EM), Oakland, California, USA.; Department of Emergency Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.; Southern Regional Disaster Response System, Atlanta, Georgia, USA., Navis IL; Chemical, Biological, Radiological, & Nuclear (CBRN) Focus Group, Pediatric Countermeasures Sub-Group, Western Regional Alliance for Pediatric Emergency Management (WRAP-EM), Oakland, California, USA., Nelsen GJ; Chemical, Biological, Radiological, & Nuclear (CBRN) Focus Group, Pediatric Countermeasures Sub-Group, Western Regional Alliance for Pediatric Emergency Management (WRAP-EM), Oakland, California, USA.; Primary Children's Hospital, Intermountain Health, Salt Lake City, Utah, USA., Cieslak TJ; Chemical, Biological, Radiological, & Nuclear (CBRN) Focus Group, Pediatric Countermeasures Sub-Group, Western Regional Alliance for Pediatric Emergency Management (WRAP-EM), Oakland, California, USA.; University of Nebraska Medical Center, Omaha, Nebraska, USA., Newton C; Chemical, Biological, Radiological, & Nuclear (CBRN) Focus Group, Pediatric Countermeasures Sub-Group, Western Regional Alliance for Pediatric Emergency Management (WRAP-EM), Oakland, California, USA.; University of California San Francisco (UCSF) - Benioff Children's Hospital, Oakland, California, USA., Lin A; Chemical, Biological, Radiological, & Nuclear (CBRN) Focus Group, Pediatric Countermeasures Sub-Group, Western Regional Alliance for Pediatric Emergency Management (WRAP-EM), Oakland, California, USA.; Division of Pediatric Hospital Medicine, Stanford School of Medicine, Stanford, California, USA., West DJ; Chemical, Biological, Radiological, & Nuclear (CBRN) Focus Group, Pediatric Countermeasures Sub-Group, Western Regional Alliance for Pediatric Emergency Management (WRAP-EM), Oakland, California, USA., Walter FG; Arizona Poison and Drug Information Center, College of Pharmacy, University of Arizona, Tucson, Arizona, USA.; Department of Pharmacy Practice and Science, College of Pharmacy, University of Arizona, Tucson, Arizona, USA.; Chemical, Biological, Radiological, & Nuclear (CBRN) Focus Group, Pediatric Countermeasures Sub-Group, Western Regional Alliance for Pediatric Emergency Management (WRAP-EM), Oakland, California, USA.; Department of Emergency Medicine, College of Medicine, University of Arizona, Tucson, Arizona, USA.; Arizona Department of Health Services (ADHS), Phoenix, Arizona, USA.
Publikováno v:
Disaster medicine and public health preparedness [Disaster Med Public Health Prep] 2024 Apr 23; Vol. 18, pp. e76. Date of Electronic Publication: 2024 Apr 23.
Autor:
Singh VK; Division of Radioprotectants, Department of Pharmacology and Molecular Therapeutics, F. Edward Hébert School of Medicine, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD, 20814-2712, USA. vijay.singh@usuhs.edu.; Armed Forces Radiobiology Research Institute, Uniformed Services University of the Health Sciences, Bethesda, MD, 20814, USA. vijay.singh@usuhs.edu., Wise SY; Division of Radioprotectants, Department of Pharmacology and Molecular Therapeutics, F. Edward Hébert School of Medicine, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD, 20814-2712, USA.; Armed Forces Radiobiology Research Institute, Uniformed Services University of the Health Sciences, Bethesda, MD, 20814, USA., Fatanmi OO; Division of Radioprotectants, Department of Pharmacology and Molecular Therapeutics, F. Edward Hébert School of Medicine, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD, 20814-2712, USA.; Armed Forces Radiobiology Research Institute, Uniformed Services University of the Health Sciences, Bethesda, MD, 20814, USA., Petrus SA; Division of Radioprotectants, Department of Pharmacology and Molecular Therapeutics, F. Edward Hébert School of Medicine, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD, 20814-2712, USA.; Armed Forces Radiobiology Research Institute, Uniformed Services University of the Health Sciences, Bethesda, MD, 20814, USA., Carpenter AD; Division of Radioprotectants, Department of Pharmacology and Molecular Therapeutics, F. Edward Hébert School of Medicine, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD, 20814-2712, USA.; Armed Forces Radiobiology Research Institute, Uniformed Services University of the Health Sciences, Bethesda, MD, 20814, USA., Lee SH; Pathology Department, Research Services, Naval Medical Research Center, Silver Spring, MD, 20910, USA., Hauer-Jensen M; Division of Radiation Health, Department of Pharmaceutical Sciences, University of Arkansas for Medical Sciences, Little Rock, AR, 72205, USA., Seed TM; Tech Micro Services, 4417 Maple Avenue, Bethesda, MD, 20814, USA.
Publikováno v:
Scientific reports [Sci Rep] 2024 Mar 08; Vol. 14 (1), pp. 5757. Date of Electronic Publication: 2024 Mar 08.
Autor:
Goldstein RH; Massachusetts Department of Public Health, Boston.
Publikováno v:
NEJM evidence [NEJM Evid] 2024 Mar; Vol. 3 (3), pp. EVIDe2300357. Date of Electronic Publication: 2024 Feb 27.
Autor:
Russ E; Division of Radioprotectants, Department of Pharmacology & Molecular Therapeutics, Uniformed Services University of the Health Sciences, Bethesda, MD, 20814, USA.; The Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, 20817, USA.; Graduate Program of Cellular and Molecular Biology, Uniformed Services University of the Health Sciences, Bethesda, MD, 20814, USA.; Armed Forces Radiobiology Research Institute, Uniformed Services University of the Health Sciences, Bethesda, MD, 20814, USA., Fatanmi OO; Division of Radioprotectants, Department of Pharmacology & Molecular Therapeutics, Uniformed Services University of the Health Sciences, Bethesda, MD, 20814, USA.; Armed Forces Radiobiology Research Institute, Uniformed Services University of the Health Sciences, Bethesda, MD, 20814, USA., Wise SY; Division of Radioprotectants, Department of Pharmacology & Molecular Therapeutics, Uniformed Services University of the Health Sciences, Bethesda, MD, 20814, USA.; Armed Forces Radiobiology Research Institute, Uniformed Services University of the Health Sciences, Bethesda, MD, 20814, USA., Carpenter AD; Division of Radioprotectants, Department of Pharmacology & Molecular Therapeutics, Uniformed Services University of the Health Sciences, Bethesda, MD, 20814, USA.; Armed Forces Radiobiology Research Institute, Uniformed Services University of the Health Sciences, Bethesda, MD, 20814, USA., Maniar M; Onconova Therapeutics, Inc., Newtown, PA, 18940, USA.; Palm Pharmaceuticals, Inc, 46750 Sentinel Drive, Fremont, CA, 94539, USA., Iordanskiy S; Division of Radioprotectants, Department of Pharmacology & Molecular Therapeutics, Uniformed Services University of the Health Sciences, Bethesda, MD, 20814, USA. sergey.iordanskiy@usuhs.edu.; Armed Forces Radiobiology Research Institute, Uniformed Services University of the Health Sciences, Bethesda, MD, 20814, USA. sergey.iordanskiy@usuhs.edu., Singh VK; Division of Radioprotectants, Department of Pharmacology & Molecular Therapeutics, Uniformed Services University of the Health Sciences, Bethesda, MD, 20814, USA. vijay.singh@usuhs.edu.; Armed Forces Radiobiology Research Institute, Uniformed Services University of the Health Sciences, Bethesda, MD, 20814, USA. vijay.singh@usuhs.edu.; Division of Radioprotectants, Department of Pharmacology and Molecular Therapeutics, F. Edward Hébert School of Medicine, 4301 Jones Bridge Road, Bethesda, MD, 20814-2712, USA. vijay.singh@usuhs.edu.
Publikováno v:
Scientific reports [Sci Rep] 2024 Feb 24; Vol. 14 (1), pp. 4518. Date of Electronic Publication: 2024 Feb 24.
Autor:
Maines LW; Apogee Biotechnology Corporation, 1214 Research Blvd, Suite 2015, Hummelstown, PA 17036, USA., Keller SN; Apogee Biotechnology Corporation, 1214 Research Blvd, Suite 2015, Hummelstown, PA 17036, USA., Smith RA; Apogee Biotechnology Corporation, 1214 Research Blvd, Suite 2015, Hummelstown, PA 17036, USA., Green CL; Apogee Biotechnology Corporation, 1214 Research Blvd, Suite 2015, Hummelstown, PA 17036, USA., Smith CD; Apogee Biotechnology Corporation, 1214 Research Blvd, Suite 2015, Hummelstown, PA 17036, USA.
Publikováno v:
International journal of molecular sciences [Int J Mol Sci] 2024 Feb 15; Vol. 25 (4). Date of Electronic Publication: 2024 Feb 15.
Autor:
Reddy DS; Department of Neuroscience and Experimental Therapeutics, Texas A&M University School of Medicine and Institute of Pharmacology and Neurotherapeutics, Texas A&M University Health Science Center, Bryan, Texas sambareddy@tamu.edu.
Publikováno v:
The Journal of pharmacology and experimental therapeutics [J Pharmacol Exp Ther] 2024 Jan 17; Vol. 388 (2), pp. 260-267. Date of Electronic Publication: 2024 Jan 17.
Autor:
Reddy DS; Department of Neuroscience and Experimental Therapeutics, Texas A&M University School of Medicine, Bryan, Texas sambareddy@tamu.edu.
Publikováno v:
The Journal of pharmacology and experimental therapeutics [J Pharmacol Exp Ther] 2024 Jan 17; Vol. 388 (2), pp. 257-259. Date of Electronic Publication: 2024 Jan 17.